Eagle Bay Advisors’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Eagle Bay Advisors’s Portfolio VAXX Stock Details VAXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-708	Closed	-$508	–	1008
2024 Q1	$508	Hold	708	–	–	﹤0.01%	945
2023 Q4	$602	Buy	708 +676	+2,113%	+$653	﹤0.01%	798
2023 Q3	$44	Buy	+32	New	+$69	﹤0.01%	854

Other funds holding VAXX

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CGL

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Eagle Bay Advisors's VAXX Position: Q2 2024 in Review

Eagle Bay Advisors sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 708 shares — an estimated $508 sold.

Eagle Bay Advisors first reported a position in VAXX in Q3 2023 and held it in 3 quarters. The position peaked at $602 in Q4 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

Eagle Bay Advisors reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
Eagle Bay Advisors sold 708 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $508.
Eagle Bay Advisors first reported a position in Vaxxinity, Inc. Class A Common Stock in Q3 2023 and held it in 3 quarters.
Eagle Bay Advisors's Vaxxinity, Inc. Class A Common Stock position peaked at $602 in Q4 2023.
8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Eagle Bay Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.